The impact of passive tobacco smoke exposure on the disease course and frequency of exacerbations in pediatric inflammatory bowel disease
Abstract
Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease, are an increasing health problem in the pediatric population, with rising incidence globally. Environmental factors are crucial in the etiology and progression of these disorders. A key modifiable risk factor is exposure to tobacco smoke, both active and passive. This study aimed to analyse current knowledge on the impact of passive smoking on the risk and course of IBD in children. The literature review shows that although a direct link between passive smoking and pediatric IBD etiology is not conclusively proven, there is strong evidence suggesting its negative effect on disease activity and prognosis. Prenatal and early childhood exposure, in particular, may influence immune mechanisms and predispose children to disease development and exacerbations. Children with IBD exposed to secondhand smoke have more frequent flare-ups, require more hospitalizations, and often need intensified immunosuppressive treatment. The importance of preventive actions is also emphasised, especially education of parents and caregivers to limit children’s exposure to tobacco smoke. Effective strategies to reduce passive smoking at home and at the legislative level are necessary. A comprehensive interdisciplinary approach covering medical, social, and legal aspects is essential to improve the quality of life among children with IBD and reduce related health and economic burdens. This analysis highlights the need…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.